Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock (BGMSP)
OTC PINK OTC PINK Primary Summary
Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| VWA VSM Wealth Advisory LLC VSM Wealth Advisory LLC | 1,882 | $7,385.91 | $2,634.8 | -$4,751.11 | -64.33% |
Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock (BGMSP) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock ever had a stock split?
Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock Profile
| Pharmaceuticals Industry | Healthcare Sector | Sing Ee Wong CEO | OTC PINK Exchange | 23254L207 CUSIP |
| US Country | 12 Employees | 22 Jan 2026 Last Dividend | - Last Split | - IPO Date |
Overview
A diversified company engaged in two major sectors: fire protection and biopharmaceuticals. The company has demonstrated strategic growth through the acquisition of Fitters Sdn. Bhd., a reputable Malaysian group specializing in fire protection products and services. By enhancing its portfolio, the company aims to leverage the synergies between its fire safety operations and its innovative biopharmaceutical research endeavors. The overarching goal is to create sustainable long-term shareholder value by exploring and advancing opportunities in both fields, ultimately positioning itself as a leader in safety solutions and healthcare advancements.
Products and Services
- Fire Protection Solutions
Offering a comprehensive range of products and services designed to ensure the safety and protection of life and property against fire hazards. These solutions include fire alarm systems, sprinkler systems, fire extinguishers, and emergency lighting, combined with professional installation and maintenance services to meet stringent safety standards.
- Biopharmaceutical Research
Engaging in groundbreaking research and development of biopharmaceuticals aimed at addressing unmet medical needs. This includes the discovery and manufacturing of innovative therapies, biologics, and vaccine development, focusing on ensuring efficacy and safety for patients.
- Consulting Services
Providing expert consulting services in fire safety regulations and biopharmaceutical compliance. This includes risk assessments, safety audits, and regulatory guidance, helping businesses navigate the complexities of fire safety standards and biopharmaceutical regulations to ensure compliance and operational excellence.
- Training and Education Programs
Offering training programs for professionals in both fire protection and biopharmaceutical industries. These programs are designed to enhance knowledge and skills in safety practices, emergency response, and the latest biopharmaceutical advancements, fostering a culture of safety and innovation.
- Fire Safety Equipment Supply
Supplying a wide range of fire safety equipment, including personal protective equipment (PPE), fire blankets, and specialized fire suppression systems for various industries. This ensures that businesses are equipped with reliable tools for preventing and managing fire emergencies.
